Quick answer

Vitex is mainly studied for premenstrual syndrome (PMS) symptoms. Some extracts have helped in trials, but the preparation and the symptom matter. For a useful comparison, check the exact extract and the symptom studied.

Start with three questions: What symptom are you trying to address? Which preparation is in the bottle? Is it suitable with your medicines and health history?

  • Match the research to the exact extract, not just the word “vitex.”
  • A trial's end date is not a personal results deadline.
  • Check the full label and medicine compatibility before starting.

How vitex relates to hormone signaling

Chasteberry is the common name for Vitex agnus-castus. Research has examined its effects on prolactin, a hormone involved in reproductive signaling. That is different from showing that it corrects every hormone problem.

The 2013 van Die review included small trials in women with a specific prolactin condition. Those findings help explain the research question, but they do not diagnose the cause of your symptoms. “Low progesterone” should not be assumed from a symptom list.

What the PMS trials actually found

The van Die review was published in 2013, not 2017. It included twelve trials: eight on PMS, two on premenstrual dysphoric disorder (PMDD) and two on a prolactin condition. Seven of the eight PMS trials favored vitex over their comparison treatment. The trials did not all use placebo or the same preparation.

In the 2001 BMJ trial, 170 women were evaluated after taking the Ze 440 extract or placebo for three menstrual cycles. The extract group improved more on the combined symptom measure. That supports a finding about this tested preparation and study group, not every retail supplement.

The 2017 Verkaik review found encouraging results but substantial study differences and risks of bias. Its authors cautioned that the pooled effect could overstate the real benefit. The authors called for better-quality trials to clarify the size of the benefit.

Which symptoms have been studied?

The BMJ trial assessed irritability, mood changes, anger, headache, breast fullness and other menstrual symptoms, including bloating. It measured a combined symptom result. It does not establish a ranked list of the symptoms vitex treats best.

PMDD research needs its own context. In the 2003 Atmaca trial, fluoxetine performed better for psychological symptoms, while vitex reduced physical symptoms. The trial was small and compared separate treatments. It did not test taking them together or prove that vitex can replace prescribed care.

For more context, read the PMS supplement guide. Keep the specific symptom and the quality of the evidence in view, rather than choosing by a broad hormone claim.

Does vitex help fertility or irregular cycles?

PMS findings are not fertility findings. NCCIH says reliable evidence is insufficient to establish a benefit for infertility. Ask about an irregular cycle or plans for pregnancy before self-treating with an herb.

PMS symptoms, irregular periods and difficulty conceiving are different questions. A PMS trial cannot tell you why a cycle is irregular or whether your chance of pregnancy will improve.

How to compare a vitex label

Do not choose from a milligram number alone. The trials used different preparations and comparison treatments. An extract amount and a whole-fruit powder amount are different label descriptions, so their numbers are not automatically interchangeable.

A universal morning dose or guaranteed three-cycle result is not established by these reviews. Follow the specific product directions and an agreed care plan. Do not increase the amount to chase faster results.

Who needs a safety check first?

Pregnancy, breastfeeding and hormone-sensitive conditions need particular caution. Medicine combinations also need review. NCCIH's chasteberry safety guidance explains these concerns and reports possible nausea, stomach discomfort, diarrhea, headache and itching.

If a product causes a new problem, review its use rather than assuming that more time or a higher amount will solve it. Traditional use is not proof that long-term use is safe for you.

Sources and practical next steps

This guide separates a study result from a supplement label. Check the preparation, the people studied and what was measured before applying a finding to your own routine.

Read the PMS, perimenopause and menopause comparison if you are unsure which topic fits your question. If you are comparing supplements for other goals, explore the current formulas and check their full labels.

Questions about vitex

What does vitex do for women?

Certain vitex extracts have shown benefits for PMS symptoms in trials. The results do not establish a general hormone-balancing effect or prove that every chasteberry supplement works the same way.

How long does vitex take to work?

Trials assess symptoms over menstrual cycles, rather than hours. A study's three-cycle endpoint is not a promise that you will notice a change by a particular month. Agree on a review plan before starting.

What is the best vitex dosage?

The preparation matters as well as the amount. Read the exact extract, serving directions and warnings. Do not assume that an amount of whole-fruit powder is interchangeable with the same amount of extract.

Can I take vitex with birth control?

Check the combination with your prescriber or pharmacist first. Bring the exact product and your medicine list. NCCIH's chasteberry safety guidance recommends checking herbal products with a healthcare provider when you take medicines.

Does vitex increase estrogen or progesterone?

Small studies in women with a specific prolactin condition reported hormone changes. They do not show that vitex reliably raises, lowers or balances hormone levels in everyone.

Is vitex safe for long-term use?

Short-term tolerability does not establish safety for years of use. NCCIH's chasteberry safety guidance describes research use of fruit extracts for up to three months. Review continued use with your healthcare provider.
Editor's note · October 13, 2026
This revision corrects the review attribution and the PMDD trial summary. It separates research timelines from promised results, removes unverified fertility and universal dosing claims, and removes unrelated outdated product cards. Original publication: March 20, 2026.
Brandon Passwaters

Brandon Passwaters

This educational article identifies its author and update date. Consult a qualified healthcare professional for personal guidance.